Nye Benjamin
Known title: DirectorCIK: 0001427438
Associated companies
Transaction History
| RPD | ▲ Buy | Grant | 15,208 | $0 | 6/9/2026 | View on chart |
| RPD | ▲ Buy | Grant | 8,420 | $0 | 6/11/2025 | View on chart |
| RPD | ▲ Buy | Grant | 1,728 | $0 | 6/11/2025 | View on chart |
| RPD | ▲ Buy | Grant | 1,855 | $0 | 6/13/2024 | View on chart |
| RPD | ▲ Buy | Grant | 5,174 | $0 | 6/13/2024 | View on chart |
| RPD | ▲ Buy | Grant | 4,297 | $0 | 6/8/2023 | View on chart |
| RPD | ▲ Buy | Grant | 1,606 | $0 | 6/8/2023 | View on chart |
| RPD | ▲ Buy | Grant | 2,877 | $0 | 6/9/2022 | View on chart |
| RPD | ▲ Buy | Option Exercise | 15,174 | $220K | 1/28/2022 | View on chart |
| RPD | ▲ Buy | Option Exercise | 12,384 | $211K | 1/28/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Rapid7 to Report Q3 2026 Results on Nov 4
Rapid7 has announced it will release its third-quarter 2026 financial results on November 4. Recent market commentary has examined whether the stock is undervalued and discussed its position among cybersecurity peers. With the stock trading near its support level, the upcoming earnings report is a key event for investors monitoring the company's performance.
Rapid7 to Report Q3 2026 Results on Nov 4. Rapid7 has announced it will release its third-quarter 2026 financial results on November 4. Recent market commentary has examined whether the stock is undervalued and discussed its position among cybersecurity peers. With the stock trading near its support level, the upcoming earnings report is a key event for investors monitoring the company's performance.